The drug makers Regeneron Pharmaceuticals and Sanofi made a rare move, negotiating with insurers in advance over the price for Dupixent.
By KATIE THOMAS from NYT Health http://ift.tt/2nIKI6n
via IFTTT
Drugs (Pharmaceuticals)
Source The New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét